The PneuVest Series
A NEW STANDARD IN COVID AIRWAY CLEARANCE SYSTEMS - IN PARTNERSHIP WITH LIFOTRONIC
PROVEN TO OPTIMISE CLINICAL RESOURCES BY REDUCING STAFF REQUIRED FOR TREATMENT USED AT MORE THAN 100 SITES IN WUHAN, CHINA AND LOMBARDY, ITALY
Ease COVID congestions, enhance outcomes
Severe lung congestion causing respiratory failure is likely to be one of the major causes of death in COVID-19 patients. It is important to remove mucus before beginning ventilation treatment. The PneuVest series high frequency chest wall oscillation (HFCWO) airway clearance system can improve the COVID recovery rate and reduce the mortality rate.
What is HFCWO?
High Frequency Chest Wall Oscillation (HFCWO) is a technology that dislodges mucus from the bronchial walls and mobilises secretions and mucus from the smaller to larger airways where it can be cleared by coughing or suction. It generates high frequency air pulses and delivers them to the chest wall of a patient via a vest.
Safe, effective, efficient
Why HFCWO is preferred for mucus removal
Safe: Compared with such traditional techniques as chest physical therapy (CPT), hand percussions etc, HFCWO is much safer as it uses gentle air pulse compression and does not cause physical injuries to ribs and muscles.
Effective: HFCWO can mobilise mucus deeply seated in the lower airways. Clinical evidence has shown that HFCWO is:
- More effective than conventional vibrating mucus removal devices
- Three times more effective than CPT
Efficient: Unlike other techniques which are performed manually by a nurse or physiotherapist, HFCWO is a highly automated system, almost plug-and-play, and operates on its own, requiring little medical staff presence. This is extremely important in a pandemic context when hospitals are running short of human resources.
Why mucus removal matters
Autopsies prove that severe mucus blockage in the lungs causing respiratory failure is likely to be one of the major causes of death in COVID-19 patients.
A leading forensic scientist urged “effective removal of mucus before use of ventilators… ventilation is useless if mucus is not removed in advance” when treating COVID-19 patients. The latest version of Guidelines for Diagnosis and Treatment of COVID-19 issued by the Chinese National Health Commission emphasises the importance of mucus removal. The latest version of Guidelines for Rehabilitation of COVID-19 Patients issued by the Chinese Medical Association Respiratory Committee recommended HFCWO specifically.
WHO ARE LIFOTRONIC?
- Chinese-based technology leader in the medtech sector
- Top supplier of therapeutic devices in China. Founded in 2008 by medtech leaders – rapid growth curve
- Listed on the Shanghai stock exchange
- 1,000+ employees, 300+ in R&D
- Over 100K device installations
- Four ISO13485 certificated factories across China with 200,000m² + manufacturing area
- National high-tech enterprise First enterprise to receive National Grade 1 Prize for Science and Technology Progress in 2015
Clarity MedTech EXCLUSIVE DISTRIBUTORS FOR LIFOTRONIC ACROSS EUROPE AND USA